Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers

Chinese Journal of Pathology

Volumn 40, Issue 8, 2011, Pages 532-536

  Wei, Wan Li ^a   Hu, Hong Yan ^a   Zhang, Li Juan ^a   Chen, Yun ^a   Ye, En ^a   Wang, Xiao Fang ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Dna methylation; Gene; Lung neoplasms; Tumor suppressor

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; PPP1R13B PROTEIN, HUMAN; PROTEIN P53; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TP53 PROTEIN, HUMAN; TP53BP2 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; DNA METHYLATION; DOWN REGULATION; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052453747     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2011.08.007     Document Type: Article

References (13)

1. Travis W.D., Brambilla E., Muller-Hermelink H.K., et al. World Health Organization classification of tumors. Pathology and genetics tumors of the lung, plrura, thymus and heart. Lyon; IARC Press, 2004:12-15.
2. Shivapurkar N., Reddy J., Chaudhary P.M., et al. Apoptosis and lung cancer. J Cell Biochem,2003,88(5) :885-898.
3. Samuels-Lev Y., O'Connor D.J., Bergamaschi D., et al. ASPP proteins specifically stimulated the apoptotic function of p53. Mol Cell, 2001,8(4) :781-794. (Pubitemid 33030212)
4. Agirre X., Roman-Gomez J., Jimenez-Velasco A., el al. ASPPl, a common activator of TP53, in inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene, 2006, 25(13) :1862-1870.
5. Ahn J., Byeon U., Byeon C.H., et al. Insight into structural basis of pro- and anti-apoptotic p53 modulation by ASPP proteins. J Biol Chem,2009,284 (20) :13812-13822.
6. Robinson R.A.,Lu X., Jones E.Y., et al. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, p73. Structure, 2008, 16 (2) :259-268. (Pubitemid 351215211)
7. Mori S., Ito G., Usanmi N., et al. P53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Cancer, 2004, 100(8) :1673-1682. (Pubitemid 38456345)
8. Mori T., Okamoto H., Takahashi N., et al. Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines. FEBS Lett, 2000,465 (2-3): 124-128 (Pubitemid 30021458)
9. Liu Z.J., Lu X., Zhang Y., et al. Downregalated mRNA expression of ASPP and the hypermethylation of the 5 '-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett, 2005, 579 (7) :1587-1590. (Pubitemid 40341527)
10. Sullivan A., Lu X. ASPP; a new family of oncogenes and tumor suppressor genes. BrJ Cancer,2007,96(2) :196-200. (Pubitemid 46160620)
11. Roman-Gomez J., Jimenez-velasco A., Agirre X., et al. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol,2005,3(28) :7043-7049.
12. Gonzalgo M.L., Hayashiba T., Bender C.M. The role of DNA methylation in expresion of P19/P16 locus in human bladder cancer cell line. Caner Res,1998,58(6) :1245-1252. (Pubitemid 28183215)
13. Tidow H., Andreeva A., Rutheeford T.J., et al. Solution structure of ASPP2 N-terminal domain (N-ASPP2) reveals a ubiquitin-like fold. J Mol Biol, 2007, 371(4) :948-958. (Pubitemid 47101808)